
Susan M Collins Stock Trades
U.S. Senator · R · ME
Disclosures through Apr 8
Every stock trade Susan M Collins has disclosed under the STOCK Act, parsed by Coldpine. Informational only, sourced from public congressional filings. Not investment advice.
Sample · the intelligence layer
Susan M Collins · Bought · Mar 24 · $15K–$50K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Susan M Collins
Get an email the moment Susan M Collins discloses a new trade. Free, no card, no spam.
Disclosure record
Susan M Collins has 3 trades on record with both a trade date and a disclosure date. The median one was disclosed 38 days after the trade, against a median of 37 days across the Senate. Of the 171 members with three or more dated trades, 34 have a longer median.
1 of them (33.3%) were disclosed more than 45 days after they were made, the STOCK Act's reporting window; across the Senate the share is 43.7%. A late report is a missed filing deadline, not a finding about the trade. Dated trades on record run from Jan 6, 2026 to Mar 24, 2026.
By the owner field on each report, every one of the 3 trades is reported as a spouse's.
Lag is the disclosure date minus the trade date, from the filing itself. Trades with a missing or implausible date (outside 0 to 1,000 days) are left out of the lag figures. How every member compares: the STOCK Act late-filer study; how the data is built: methodology.
Filings all 3All filings, newest first
Recent disclosed trades
| Date | Ticker | Asset | Type | Amount |
|---|---|---|---|---|
| Mar 24 | — | Cumberland Cnty ME 230525LY1 Rate/Coupon: 4.000% Matures: 2035-04-01 | buy | $15K–$50K |
| Feb 3 | — | Pfizer Inc 717081FE8 Rate/Coupon: 4.500% Matures: 2032-11-15 | buy | $15K–$50K |
| Jan 6 | — | ME St Health & Higher Ed 56042RG22 Rate/Coupon: 2.500% Matures: 7/1/2029 | buy | $50K–$100K |
From Coldpine Research
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →